{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:40:40Z","timestamp":1790714440613,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T00:00:00Z","timestamp":1130371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The anaemia associated with chronic renal failure is multi\u2010factorial. Although a relative erythropoietin deficiency is a major factor, it has also been recognized in recent times that uraemia is a chronic inflammatory state, and thus patients with renal failure also develop anaemia due to mechanisms associated with chronic inflammation. Thus, patients with chronic renal failure have activation of various immune cells, both monocytes and T\u2010cells. These mononuclear cells have also been shown to release pro\u2010inflammatory cytokines such as IL\u20101, IL\u20106, TNF\u2010alfa and interferon gamma. These cytokines, particularly TNF\u2010alfa and interferon gamma, are known to cause significant suppression of erythropoiesis. The exact molecular mechanism for this effect is not yet clear, but interferon gamma is an important stimulator of apoptosis in various cell types, including erythroid progenitor cells. This effect may be potentiated by other cytokines such as TNF\u2010alfa, and this might then antagonise the anti\u2010apoptotic action of erythropoietin on erythroid progenitors cells, thus reducing responsiveness to exogenous erythropoietic therapy. Chronic renal failure is also associated with increased hepcidin production which may also exacerbate the anaemia by inducing a functional iron deficiency in such patients.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2005.01528.x","type":"journal-article","created":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T16:25:40Z","timestamp":1130430340000},"page":"32-35","source":"Crossref","is-referenced-by-count":50,"title":["Hyporesponsiveness to erythropoietic therapy due to chronic inflammation"],"prefix":"10.1111","volume":"35","author":[{"given":"I. C.","family":"Macdougall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,27]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.22"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90357-1"},{"key":"e_1_2_7_4_2","first-page":"449","article-title":"Erythropoietin levels in uremic nephric and anephric patients","volume":"93","author":"Caro J","year":"1979","journal-title":"J Lab Clin Med"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000417892"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V10112392","article-title":"Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients","volume":"10","author":"Macdougall IC","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_7_2","first-page":"607","article-title":"Poor response to erythropoietin: practical guidelines on investigation and management","volume":"10","author":"Macdougall IC","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg167"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14567-9"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00981.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139x.2000.00044.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000014417"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.07839.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046941"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139x.2000.00110.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.7.953"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1271549"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9631845"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.12.2807"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186276"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V991689"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.70"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1681\/ASN.V10102171","article-title":"Hemodialysis\u2010related lymphomononuclear release of interleukin\u201012 in patients with end\u2010stage renal disease","volume":"10","author":"Memoli B","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_24_2","first-page":"52","article-title":"Synthesis of tumor necrosis factor alpha and interleukin\u20101 receptor antagonist, but not interleukin\u20101, by human mononuclear cells is enhanced by exposure of whole blood to shear stress","volume":"42","author":"Pomianek MJ","year":"1996","journal-title":"ASAIO J"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.8.1217"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045516"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.26092"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.7.1639.1639"},{"key":"e_1_2_7_29_2","first-page":"1235","article-title":"Fas ligand is present in human erythroid colony\u2010forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis","volume":"15","author":"Dai CH","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_30_2","first-page":"204","article-title":"Inhibition of CFU\u2010E colony formation in uremic patients with inflammatory disease. role of IFN\u2010gamma and TNF\u2010alpha","volume":"47","author":"Allen DA","year":"1999","journal-title":"J Investig Med"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000071514.36428.61"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000131523.17045.56"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg560"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2005.01528.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2005.01528.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:48:53Z","timestamp":1695746933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2005.01528.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,27]]},"references-count":32,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1365-2362.2005.01528.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01528.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,27]]}}}